Danielle Houwing

Publications

Displaying 1 - 2 of 2
  • Rivera-Olvera, A., Houwing, D. J., Ellegood, J., Masifi, S., Martina, S., Silberfeld, A., Pourquie, O., Lerch, J. P., Francks, C., Homberg, J. R., Van Heukelum, S., & Grandjean, J. (2024). The universe is asymmetric, the mouse brain too. Molecular Psychiatry. Advance online publication, 2023.09.01.555907. doi:10.1038/s41380-024-02687-2.

    Abstract

    Hemispheric brain asymmetry is a basic organizational principle of the human brain and has been implicated in various psychiatric conditions, including autism spectrum disorder. Brain asymmetry is not a uniquely human feature and is observed in other species such as the mouse. Yet, asymmetry patterns are generally nuanced, and substantial sample sizes are required to detect these patterns. In this pre-registered study, we use a mouse dataset from the Province of Ontario Neurodevelopmental Network, which comprises structural MRI data from over 2000 mice, including genetic models for autism spectrum disorder, to reveal the scope and magnitude of hemispheric asymmetry in the mouse. Our findings demonstrate the presence of robust hemispheric asymmetry in the mouse brain, such as larger right hemispheric volumes towards the anterior pole and larger left hemispheric volumes toward the posterior pole, opposite to what has been shown in humans. This suggests the existence of species-specific traits. Further clustering analysis identified distinct asymmetry patterns in autism spectrum disorder models, a phenomenon that is also seen in atypically developing participants. Our study shows potential for the use of mouse models in studying the biological bases of typical and atypical brain asymmetry but also warrants caution as asymmetry patterns seem to differ between humans and mice.

    Additional information

    tables link to preprint on BioRxiv
  • Houwing, D. J., Schuttel, K., Struik, E. L., Arling, C., Ramsteijn, A. S., Heinla, I., & Olivier, J. D. (2020). Perinatal fluoxetine treatment and dams’ early life stress history alter affective behavior in rat offspring depending on serotonin transporter genotype and sex. Behavioural Brain Research, 392: 112657. doi:10.1016/j.bbr.2020.112657.

    Abstract

    Many women diagnosed with a major depression continue or initiate antidepressant treatment during pregnancy. Both maternal stress and selective serotonin inhibitor (SSRI) antidepressant treatment during pregnancy have been associated with changes in offspring behavior, including increased anxiety and depressive-like behavior. Our aim was to investigate the effects of the SSRI fluoxetine (FLX), with and without the presence of a maternal depression, on affective behavior in male and female rat offspring. As reduced serotonin transporter (SERT) availability has been associated with altered behavioral outcome, both offspring with normal (SERT+/+) and reduced (SERT+/−) SERT expression were included. For our animal model of maternal depression, SERT+/− dams exposed to early life stress were used. Perinatal FLX treatment and early life stress in dams (ELSD) had sex- and genotype-specific effects on affective behavior in the offspring. In female offspring, perinatal FLX exposure interacted with SERT genotype to increase anxiety and depressive-like behavior in SERT+/+, but not SERT+/−, females. In male offspring, ELSD reduced anxiety and interacted with SERT genotype to decrease depressive-like behavior in SERT+/−, but not SERT+/+, males. Altogether, SERT+/+ female offspring appear to be more sensitive than SERT+/− females to the effects of perinatal FLX exposure, while SERT+/− male offspring appear more sensitive than SERT+/+ males to the effects of ELSD on affective behavior. Our data suggest a role for offspring SERT genotype and sex in FLX and ELSD-induced effects on affective behavior, thereby contributing to our understanding of the effects of perinatal SSRI treatment on offspring behavior later in life.

Share this page